Salarius Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
SLRX Key Statistics
Stock Snapshot
Salarius Pharmaceuticals(SLRX) stock is priced at $0.69, giving the company a market capitalization of 4.08M. It carries a P/E multiple of -0.02.
As of 2025-12-20, Salarius Pharmaceuticals(SLRX) stock has fluctuated between $0.66 and $0.72. The current price stands at $0.69, placing the stock +5.3% above today's low and -3.7% off the high.
Salarius Pharmaceuticals(SLRX) shares are trading with a volume of 225.36K, against a daily average of 344.66K.
During the past year, Salarius Pharmaceuticals(SLRX) stock moved between $0.64 at its lowest and $108.00 at its peak.
During the past year, Salarius Pharmaceuticals(SLRX) stock moved between $0.64 at its lowest and $108.00 at its peak.
SLRX News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Salarius Pharmaceuticals (SLRX) announced that in connection with its recent combination with Decoy Therapeutics (DCOY), the Company intends to change its corpo...